Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2021-11-16 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
【易明医药】2019年限制性股票第二次解除限售的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2019 restricted stock incentive plan of a company, specifically about the second unlocking of restricted shares. It contains detailed legal analysis, references to company board and shareholder meetings, audit reports, and compliance with regulatory requirements. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to a stock incentive plan and its compliance and approval process. This fits best under the category of Regulatory Filings (RNS) as it is a legal compliance document and does not fit other categories like Remuneration Information or Capital/Financing Update. The document length is over 11,000 characters, indicating it is a full legal opinion rather than a brief announcement or certification. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2021-11-16 Chinese
独立董事关于第三届董事会第三次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding matters discussed at the third meeting of the third board of directors. It specifically addresses the legality and compliance of a restricted stock incentive plan and the lifting of restrictions on shares for certain incentive recipients. There is no financial data or comprehensive report content, but rather a formal opinion on board matters related to stock incentives. This fits the category of Board/Management Information (MANG), which includes announcements of board decisions and related opinions.
2021-11-16 Chinese
第三届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the third meeting of the third board of directors of the company. It details the meeting date, attendance, voting results on various proposals, and references to related announcements and documents. The content focuses on board decisions and governance matters, such as stock incentive plans, amendments to business scope and articles of association, and scheduling a shareholders' meeting. There is no financial data, earnings information, or audit content. The document is not a full report but a formal announcement of board meeting decisions, fitting the category of Board/Management Information (MANG). The document length is short and it is a direct announcement, not a report publication or regulatory filing. Therefore, the classification is MANG with high confidence.
2021-11-16 Chinese
西藏易明西雅医药科技股份有限公司章程（2021年11月修订）
Governance Information Classification · 100% confidence The document is titled "西藏易明西雅医药科技股份有限公司 章程" which translates to "Articles of Association of Tibet Aim Pharm. Inc." It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and other governance-related matters. The content is focused on the company's internal rules, shareholder meetings, board structure, and governance practices. There is no indication that this is an annual report, financial statement, or any other type of report. Instead, it is a governance document outlining the company's articles of association, which is a classic example of Governance Information filings. The document length is substantial (15,000 characters), and it is not a mere announcement or certification. Therefore, the appropriate classification is Governance Information (CGR).
2021-11-16 Chinese
关于召开2021年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2021 second extraordinary general meeting of shareholders for a company, detailing the meeting time, location, voting methods, agenda items, and procedures for attendance and voting. It includes information about the proposal to increase business scope and amend the articles of association, voting instructions, and proxy forms. There are no financial statements or financial performance data presented. The document is an announcement of a shareholders meeting and related voting information, not a report or results announcement. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2021-11-16 Chinese
2021年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "西藏易明西雅医药科技股份有限公司 2021 年第三季度报告" which translates to "Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. 2021 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes for the third quarter of 2021. The document is approximately 15,000 characters long and includes comprehensive financial information for a period shorter than a full fiscal year (the third quarter). It is not an announcement of a report but the report itself, containing substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2021
2021-10-24 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.